METFORMIN XR DIN 02565528
Health Canada record
| Active ingredient(s) | METFORMIN HYDROCHLORIDE 500 MG |
|---|---|
| Dosage form | Tablet (Extended-Release) |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | A10BA02 METFORMIN |
| Original market date | |
| Current status date | 03-Feb-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing METFORMIN HYDROCHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02305062 | APO-METFORMIN ER | APOTEX INC | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02099233 | GLUCOPHAGE | SANOFI-AVENTIS CANADA INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02268493 | GLUMETZA | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02300451 | GLUMETZA | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 1000 MG | Marketed |
| 02268507 | GLUMETZA (SB) | BAUSCH HEALTH, CANADA INC. | Tablet (Extended-Release) | METFORMIN HYDROCHLORIDE 1000 MG | Approved |
| 02378051 | IPG-METFORMIN | MARCAN PHARMACEUTICALS INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Approved |
| 02378043 | IPG-METFORMIN | MARCAN PHARMACEUTICALS INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Approved |
| 02353377 | METFORMIN | SANIS HEALTH INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02229517 | METFORMIN | APOTEX INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Approved |
| 02353385 | METFORMIN | SANIS HEALTH INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Marketed |
| 02162822 | METFORMIN | APOTEX INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Approved |
| 02378116 | PG-METFORMIN | MARCAN PHARMACEUTICALS INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Approved |
| 02314908 | PRO-METFORMIN | PRO DOC LIMITEE | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02314894 | PRO-METFORMIN | PRO DOC LIMITEE | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Marketed |
| 02246821 | SANDOZ METFORMIN FC | SANDOZ CANADA INCORPORATED | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Marketed |
| 02246820 | SANDOZ METFORMIN FC | SANDOZ CANADA INCORPORATED | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02257734 | TEVA-METFORMIN | TEVA CANADA LIMITED | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Marketed |
| 02257726 | TEVA-METFORMIN | TEVA CANADA LIMITED | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Marketed |
| 02167786 | APO-METFORMIN | APOTEX INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Dormant |
| 02229785 | APO-METFORMIN | APOTEX INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Dormant |
| 02364506 | AVA-METFORMIN | AVANSTRA INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02364514 | AVA-METFORMIN | AVANSTRA INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02265583 | BCI METFORMIN | BAKER CUMMINS INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02265575 | BCI METFORMIN | BAKER CUMMINS INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02229994 | DOM-METFORMIN | DOMINION PHARMACAL | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02242726 | DOM-METFORMIN | DOMINION PHARMACAL | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02162849 | GLUCOPHAGE | SANOFI-AVENTIS CANADA INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02239214 | GLYCON | BAUSCH HEALTH, CANADA INC. | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Dormant |
| 02229516 | GLYCON | BAUSCH HEALTH, CANADA INC. | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Dormant |
| 02230670 | MED METFORMIN TABLETS 500MG | MEDICAN PHARMA INCORPORATED | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02343606 | METFORMIN | COBALT PHARMACEUTICALS COMPANY | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Pre Market |
| 02231389 | METFORMIN | BDH INC. | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02238827 | METFORMIN | LABORATOIRES CONFAB INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Pre Market |
| 02242793 | METFORMIN | SORRES PHARMA INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02242794 | METFORMIN | MELIAPHARM INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02246965 | METFORMIN | MELIAPHARM INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02284782 | METFORMIN | MYLAN PHARMACEUTICALS ULC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02284790 | METFORMIN | MYLAN PHARMACEUTICALS ULC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02343614 | METFORMIN | COBALT PHARMACEUTICALS COMPANY | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Pre Market |
| 02230026 | METFORMIN TABLETS 500MG | PREMPHARM INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02220628 | METFORMIN-500 - TAB 500MG | PRO DOC LIMITEE | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02231058 | METFORMIN-850 | PRO DOC LIMITEE | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02148765 | MYLAN-METFORMIN | MYLAN PHARMACEUTICALS ULC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02229656 | MYLAN-METFORMIN | MYLAN PHARMACEUTICALS ULC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02361272 | NTP-METFORMIN | NT PHARMA CANADA LTD | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Pre Market |
| 02361264 | NTP-METFORMIN | NT PHARMA CANADA LTD | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Pre Market |
| 02246614 | ORB-METFORMIN | ORBUS PHARMA INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled (Unreturned Annual) |
| 02246613 | ORB-METFORMIN | ORBUS PHARMA INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled (Unreturned Annual) |
| 02246964 | PHL-METFORMIN | PHARMEL INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02242589 | PMS-METFORMIN | PHARMASCIENCE INC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Dormant |
| 02223562 | PMS-METFORMIN - TAB 500MG | PHARMASCIENCE INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Dormant |
| 02339110 | Q-METFORMIN | QD PHARMACEUTICALS ULC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02339129 | Q-METFORMIN | QD PHARMACEUTICALS ULC | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02269058 | RAN-METFORMIN | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02269031 | RAN-METFORMIN | RANBAXY PHARMACEUTICALS CANADA INC. | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02242931 | RATIO-METFORMIN | TEVA CANADA LIMITED | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
| 02242974 | RATIO-METFORMIN | TEVA CANADA LIMITED | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02233999 | RHOXAL-METFORMIN | RHOXALPHARMA INC | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02045710 | TEVA-METFORMIN | TEVA CANADA LIMITED | Tablet | METFORMIN HYDROCHLORIDE 500 MG | Cancelled Post Market |
| 02230475 | TEVA-METFORMIN | TEVA CANADA LIMITED | Tablet | METFORMIN HYDROCHLORIDE 850 MG | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 36830 | 2026-02-03 | Abbreviated New Drug Submission (ANDS) | Administrative: Licensing Agreement between two manufacturers |
International API supply for METFORMIN HYDROCHLORIDE
24 valid EDQM Certificates of Suitability from 24 holders. 34 active FDA Drug Master Files.
Request a quote for METFORMIN XR